![(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine](https://static.cymitquimica.com/products/3D/img/FD103522.png "Click to enlarge")
(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine
CAS: 1226781-44-7
Ref. 3D-FD103522
| 25g | To inquire | |
| 50g | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire | |
| 500mg | To inquire |
Product Information
- (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine
- 2H-Pyran-3-amine, 2-(2,5-difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-, (2R,3S,5R)-
- Mk-3102
(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine is a pyrazole derivative that binds to the enzyme dipeptidyl peptidase IV (DPP IV) and inhibits the activity of dipeptidyl peptidase I (DPP I). The inhibition of these enzymes leads to an increase in insulin secretion. This drug has been shown to be effective against type 2 diabetes mellitus and metabolic disorders. It also shows efficacy in reducing postprandial blood glucose levels. The binding affinity was determined using a matrix effect. The inhibitor binding constants were found by analytical methods. Blood sampling was done for concentration-time curves to determine the pharmac
Chemical properties
Technical inquiry about: 3D-FD103522 (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
